Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

SV Rajkumar, JL Harousseau, B Durie, KC Anderson, M Dimopoulos, R Kyle, J Blade, P Richardson, R Orlowski, D Siegel, S Jagannath, T Facon, H Avet-Loiseau, S Lonial, AA Palumbo, J Zonder, H Ludwig, D Vesole, O Sezer, NC MunshiJ San Miguel

Research output: Contribution to journalArticleAcademicpeer-review

688 Citations (Scopus)

Abstract

It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript. (Blood. 2011; 117(18): 4691-4695)
Original languageUndefined/Unknown
Pages (from-to)4691-4695
Number of pages5
JournalBlood
Volume117
Issue number18
Publication statusPublished - 2011

Cite this